Lectenz Bio News

Lectenz Bio sponsored SialoGlyco 2024 in Lille, France. Principal Scientist Sylvain Lehoux presented on the development and use of our...

NIH sponsored Lectenz Bio’s attendance at the BIO International Convention 2024. CEO and CSO Lori Yang gave a Company Presentation.

Lectenz Bio has recently signed a distribution agreement with AmyJet Scientific Inc., a Chinese life science distributor. This agreement...

It's Rare Disease Day 2024! We're always excited to see how glycobiology research impacts patient treatments and are proud to be...

Glycan analysis poses significant challenges due to the intricate nature of glycan structures and their diverse compositions, making...

Lectenz Bio attended and sponsored the Society for Glycobiology 2023 Annual Meeting in Hawaii. VP of R&D Sean Wu presented our poster,...

Lectenz Bio has recently signed a distribution agreement with Labscoop, a U.S. life science distributor. This agreement will allow...

Lectenz Bio has recently signed a distribution agreement with Apical Lab Corp., a Taiwanese life science distributor. This agreement will...

The National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to...